Path 2

targeted cellular responses

CytoComm™ for Cardiology

CytoComm™ is being designed to allow wireless monitoring in at-risk cardiac patients. CytoComm™ will provide real-time patient information, allowing physicians to take preemptive and potentially life-saving action before a significant event (i.e. heart attack) occurs. 

Cardiovascular disease is expensive, debilitating, and deadly. Before heart failure ever occurs, the human body produces biomarkers – BNP, epinephrine, troponin, etc. – that signal an event is likely to occur.  Current monitoring methods to measure these biomarkers are unfortunately hampered by a lack of effective and personalized in vivo tools. Using living cells to collect rich and physiologically relevant information, CytoComm™ is being built to notify physicians of increased precursor levels and allow for a proactive course of treatment.


  • More Data, More Often
    CytoComm™ is designed to provide real-time patient data to clinicians, available 24 hours a day, 7 days a week.
  • Information Available Where You Are
    Gather vital information from anywhere, not only in the office or hospital.
  • Preemptive Treatment
    Data is wirelessly sent to the “cloud” where it is analyzed and securely accessible anytime, from anywhere